Evidence map›Paper›PMID 41767878›Full record

ArticleJournal of analytical methods in chemistry2026

The Effect of Hemolysis on Biochemical Tests: Determining Interference Cutoffs and Managing Hemolytic Samples.

Babak Shirazi Yeganeh, Neda Soleimani, Saeedeh Zare, Sahand Mohammadzadeh, Farzaneh Amiri, Mohammad Javad Esmaeili, Davoud Soleimani, Soodabeh Khoshnyat

Abstract read
In one paragraph

Article in Journal of analytical methods in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Babak Shirazi YeganehDepartment of Pathology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0000-0001-6373-4376
Neda SoleimaniDepartment of Pathology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0000-0001-5769-8452
Saeedeh ZareDepartment of Pathology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0009-0008-1494-9766
Sahand MohammadzadehDepartment of Pathology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0000-0001-6974-1323
Farzaneh AmiriDepartment of Pathology, Shiraz Transplant Center, Abu Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0009-0009-5797-8492
Mohammad Javad EsmaeiliDepartment of Pathology, Shiraz Transplant Center, Abu Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0009-0005-0934-666X
Davoud SoleimaniCenter of Policy Planning, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0009-0005-5215-4890
Soodabeh KhoshnyatDepartment of Pathology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0009-0005-2545-7765

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hemolysis is a common source of interference in biochemical tests, potentially leading to significant errors in clinical decision-making and patient management. This study aimed to evaluate the impact of varying degrees of hemolysis on routine biochemical analytes and to find a local hemolytic index (HIX) cutoff for safe reporting. Methods: This experimental study was conducted on 30 serum samples from healthy individuals with normal biochemical profiles. Baseline concentrations of 20 routine analytes were measured using a DIRUI CS-1200 analyzer. To simulate hemolysis, increasing concentrations of autologous hemolysate were added to each sample, creating three grades of hemolysis based on HIX (mild, moderate, and severe). All analytes were remeasured, and the absolute and relative biases were calculated against baseline levels. These biases were then compared with the CLIA-defined total allowable error (TEa) to obtain the safe reporting cutoff for each analyte. Results: All analytes showed a positive bias with increasing hemolysis, though the magnitude of interference varied significantly. LDH, uric acid, AST, and total bilirubin, in that order, were more impacted by hemolysis. In mild hemolysis (HIX < 0.5), none of the analyte biases exceeded TEa limits ( Conclusion: Hemolysis interference is both analyte- and system-dependent. Laboratories are recommended to conduct similar research tailored to their local laboratory settings and population to improve analytical quality and reduce unnecessary specimen rejection.

Indexed as

biochemistryhemolysishemolytic indexinterference

Identifiers

PMID41767878
PMCPMC12946476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.